Stay updated on XMT-1660 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedNew enrollment and help navigation items were added to the study details page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. A formatting change in the Intervention/Treatment label replaces the previous Intervention / Treatment and the documentation revision note advanced from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check10 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov entry was published.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new Revision: v3.5.4 appears, replacing the previous Revision: v3.5.3. This indicates a minor metadata update to the page's release tag.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s footer revision indicator was updated from “v3.5.2” to “v3.5.3,” indicating a system/version update with no change to the displayed study details.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded UCLA David Geffen School of Medicine, Division of Hematology/Oncology and Sarah Cannon Research Institute (SCRI) with investigator Jennifer Specht, MD. Removed UCLA and Tennessee Oncology, PLLC and Natasha Hunter, MD.SummaryDifference0.3%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details page.SummaryDifference0.0%

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.